Navigation Links
Vitamin D With NSAID Drugs May Prevent Prostate Cancer

A low dose of Vitamin D with non-steroidal anti- inflammatory drugs may prevent the growth of prostate cancer cells, says a study.//

David Feldman and other researchers at Stanford University studied the effects of using calcitrol, a form of Vitamin D, combined with an over-the-counter anti-inflammatory drug on prostate cancer cultured cells, reports the online edition of Ivanhoe Broadcast News.

The researchers saw a 25 percent reduction in prostate cell growth using only calcitrol. They noticed approximately the same reduction using only ibuprofen or naproxen.

But the prostate cell growth came down by 70 percent when they combined calcitrol with ibuprofen or naproxen.

"Non-steroidal anti-inflammatory drugs (such as ibuprofen or naproxen) have their own risks," says Feldman.

"So, we have to be careful even with lower doses and we still need to watch them closely if we intend to keep them on these drugs for extended periods of time. But we are aiming to find doses that are less toxic and far more tolerable for the patient."

Source - IANS
'"/>




Page: 1

Related medicine news :

1. Vitamin B12 can help in detecting cancers
2. Vitamins-The answer to Heart Disease?
3. Vitamin E, the latest warrior against diabetes
4. Vitamin Shields Brittle Bones
5. B Vitamin protects and lowers toxicity of Arthritis Drug
6. B Vitamin Supplementatoin Saves Money and Lives
7. Eat Vitamin C and stay young
8. Vitamin C for the heart
9. Vitamin B for Hepatitis
10. Vitamins reduce pre-eclampsia
11. Vitamin E useful for Alzheimers
Post Your Comments:
(Date:10/6/2008)...pecial supplement of the Oct. 15,journal Cancer fo...iddle-income countries to implement breast cancer ...se among women worldwide., "Guidelines for Intern...ntation" developed by the Breast Health Global Ini...e allocation -- based on countries,overall econom...
(Date:10/6/2008)...ently posted detailed information on its Cimzia in... side effects caused by the drug and its family kn...side effects are the development of fatal infectio...hild patients. , Denver, ...r one resource for everything and anything legal o...
(Date:10/6/2008)...ased civil litigation and criminal defense firm re...y awarded $3.2 million to plaintiff earlier this y...nd ((Lexis Nexis) October 6, 2008 -- Attorneys in ...Murtha & Psoras] have successfully resolved a ... welder who was awarded more than $3 million by a ...
(Date:10/5/2008)...elp detect serious bacterial infections (SBIs) lik...ions in young infants who come to the emergency de.... Researchers at Children,s Hospital Boston, colla...niversity, show that a new diagnostic marker calle...risk for SBIs while potentially reducing unnecessa...
Breaking Medicine News(10 mins):Health News:International Implementation of Breast Health Guidelines for Developing Countries Published by Cancer 2Health News:International Implementation of Breast Health Guidelines for Developing Countries Published by Cancer 3Health News:LegalView Informs Patients of Possible Cimzia Cancer Link, Drug Commonly Used to Treat Arthritis 2Health News:LegalView Informs Patients of Possible Cimzia Cancer Link, Drug Commonly Used to Treat Arthritis 3Health News:Miller, Murtha & Psoras Secures Multimillion-Dollar Settlement for Victim of Industrial Accident at Bethlehem Steel 2Health News:New test could help catch serious infections in babies 2
...atest Journal of Advanced Nursing says expresses d...en education and practice in the nursing professio...on University says that despite sincere efforts by... change, the basic problems identified by Eve Bend...
...demy of Sciences (NAS) has chosen 15 scientists to...chievements. The awards will be presented on Apri...the Academy's 143rd annual meeting. The 2006 award... J. Carty Award FOR The Advancement Of Science, es...
...d on the sales pan masala and tobacco products nea...rala State Government in India. The products can b...tutions, according to the new rules. //A law is al...t this is strictly adhered to. The youth in the ...
...icer of Ontario has announced that it will be diff...tious disease outbreak. Many of Ontario's public h...on a full time basis,// and provincial laboratorie... equipment. The Province may be incapable of deali...
Other Medicine News:Health News:What nurses learn is not what they practice 2Health News:US Academy honors 15 for major contributions to science 2Health News:US Academy honors 15 for major contributions to science 3Health News:US Academy honors 15 for major contributions to science 4Health News:US Academy honors 15 for major contributions to science 5
(Date:10/6/2008)...ct - Company,s Bioabsorbable Stent - Also,Slated f...- Data from multiple clinical trials ...,s Genous Bio-engineered R,stent, will be presente...erapeutics symposium, TCT 2008, in Washington, D.C...c Medical Center in,Amsterdam will provide a Genou...
(Date:10/3/2008)...wire-FirstCall/ -- Amsterdam Molecular,Therapeutic...gene therapy,announced today that it intends to i...orization Application (MAA) for Glybera(R) for Lip...ilitating and potentially lethal,disease., The da...ies (22,patients in total) demonstrate that Glyber...
(Date:10/2/2008)...sults of Rosetta Genomics, microRNA-based,Test, mi...From non Squamous non Small Cell Lung Cancer,...the miRview(TM) Technology First Approved for Clin...plexity Molecular Pathology Lab ...pecting to Launch miRview(TM) Squamous Later This ...
(Date:10/2/2008)...wire/ -- Athera Biotechnologies AB and Dyax,Corp. ...ered into a,collaboration to discover and to devel...tment of cardiovascular inflammatory diseases., T... work by Athera,scientific founders, Professors Fr.... The research links naturally occurring antibodie...
Breaking Medicine Technology:Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2008 2Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2008 3AMT Intends to Incorporate Additional Data to its Marketing Authorization Dossier for Glybera(R) 2AMT Intends to Incorporate Additional Data to its Marketing Authorization Dossier for Glybera(R) 3Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 2Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 3Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 4Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 5Athera Biotechnologies and Dyax Announce a Collaboration to Discover and Develop Antibodies for Cardiovascular Inflammation 2Athera Biotechnologies and Dyax Announce a Collaboration to Discover and Develop Antibodies for Cardiovascular Inflammation 3Athera Biotechnologies and Dyax Announce a Collaboration to Discover and Develop Antibodies for Cardiovascular Inflammation 4National Long Term Care Leaders to Release New Data Discuss Negative National Economic Jobs Impact 18955 1AutoImmune Inc Reports 2008 First Quarter Financial Results 18952 1AutoImmune Inc Reports 2008 First Quarter Financial Results 18952 2AutoImmune Inc Reports 2008 First Quarter Financial Results 18952 3Web Site Helps Patients Prepare for Hospital Stay 18948 1Web Site Helps Patients Prepare for Hospital Stay 18948 2Web Site Helps Patients Prepare for Hospital Stay 18948 3Development of new techniques to understand marble quality and durability 3248 1Development of new techniques to understand marble quality and durability 3248 2
...O, June 18, 2007 /PRNewswire-FirstCall/ -- Vical,I...ensee, AnGes MG,Inc. reported positive results fo... subjects to complete a Phase 3 trial of an,angiog...y,technology. Based on the findings that the prima...d with statistical,significance and that there wer...
...Italy, June 15 /CNW/ - Today AMADEO, one of the,fi...f two,angiotensin receptor blockers in hypertensi...ed at the European Society,of Hypertension, Milan...an reduces proteinuria to a significantly greater ...he results, Prof. Ellen Burgess, Foothills Hospita...
Other Medicine Technology:Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 2Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 3Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 4Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 5New Study Shows That telmisartan has Greater Renoprotective,Potential Thanlosartan in Hypertensive Patients With Type 2,Diabetes 2New Study Shows That telmisartan has Greater Renoprotective,Potential Thanlosartan in Hypertensive Patients With Type 2,Diabetes 3New Study Shows That telmisartan has Greater Renoprotective,Potential Thanlosartan in Hypertensive Patients With Type 2,Diabetes 4New Study Shows That telmisartan has Greater Renoprotective,Potential Thanlosartan in Hypertensive Patients With Type 2,Diabetes 5
This new dedicated VICTOR2 model is for fluorescence and luminescence measurements.
VICTOR2 V measures prompt fluorescence, fluorescence polarization, luminescence, time-resolved fluorescence and absorbance. This model includes high density TRF (for 1536-well plates), temperature
This a new dedicated VICTOR2 model for fluorescence and luminescence detection with stacker and robotic loading.
The basic modular version of the VICTOR2 multilabel counter for fluorescence, luminescence and absorption measurements, with the stacker and the robotic loading configuration.
Medicine Products: